Blood News and Research

RSS

Scientists describe how protein acts as courier in cell signaling pathways

Normal development, from fertilized egg to adult organism, depends on each cell receiving proper instructions from its environment. In response to such incoming information, receptors on a cell's surface send signals to the nucleus that tweak gene expression and control cellular function.

28 Oct 2011

Patients with ANCA-associated vasculitis harbor Flt1 protein that blocks blood vessel repair

In some kidney diseases, patients have high blood levels of a protein that blocks blood vessel repair, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

28 Oct 2011

Three economic indicators linked with high risk of stroke

People living in poor countries or countries that spend proportionately less on health-care are about 30 per cent more likely to have a stroke, a new study shows.

28 Oct 2011

Special hospital team reduces cumulated risk of stroke in TIA patients

28 Oct 2011

Social stressors around the transition into adulthood sow seeds of disease in middle age

Being hard up socially and financially during adolescence and early adulthood takes its toll on the body, and leads to physiological wear and tear in middle aged men and women, irrespective of how tough things have been in the interim. According to Dr. Per E. Gustafsson from Umeå University in Sweden and colleagues, experience of social and material stressors around the time of transition into adulthood is linked to a rise in disease risk factors in middle age, including higher blood pressure, body weight and cholesterol.

28 Oct 2011

No significant evidence of breast cancer after nipple-sparing mastectomy

A modified mastectomy technique provides effective treatment for breast cancer while preserving the nipple and surrounding tissues for use in breast reconstruction, according to a report in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

28 Oct 2011

DiaGenic reports operating revenue of NOK 276 thousand for third quarter 2011

DiaGenic has successfully finalized the first clinical study in collaboration with Pfizer, the market leader for Alzheimer's therapeutics sales and Pfizer has confirmed DiaGenic's findings resulting in a press release October 14th.

28 Oct 2011

Novel technique saves Gulf War veteran's forearm

A plastic surgeon at UT Southwestern Medical Center recently used a novel technique to save the arm of a Gulf War veteran who was rushed to Parkland Memorial Hospital after a horrific accident.

28 Oct 2011

Swapping IV medications with oral equivalents may save millions

Switching hospitalized patients able to take medication by mouth from intravenous to pill forms of the same drugs could safely save millions of dollars a year, new Johns Hopkins research suggests.

28 Oct 2011

Novel stem cells method may eliminate need for antirejection drugs in transplants

Surgical researchers at the University of Washington, Seattle, have pioneered a method using stem cells that may one day eliminate the need for antirejection drugs in transplants. Primary investigator David Mathes, MD, FACS, and his research fellow Jeff Chang, MD, MS, presented their findings today at the 2011 Clinical Congress of the American College Surgeons.

28 Oct 2011

Fasudil drug shows promise against cerebral cavernous malformation

A drug treatment has been proven to prevent lesions from cerebral cavernous malformation — a brain blood vessel abnormality that can cause bleeding, epilepsy and stroke — for the first time in a new study.

28 Oct 2011

Nestin-driven oncolytic viruses show effectiveness in glioblastoma models

A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer.

28 Oct 2011

Advanced papillary thyroid cancer patients with BRAFV600E gene mutation at higher risk

Individuals with advanced papillary thyroid cancer (PTC) that are associated with the BRAFV600E gene mutation have a higher risk of recurrent disease and progression to more advanced, poorly differentiated thyroid cancer, according to data presented today at the 81st Annual Meeting of the American Thyroid Association (ATA).

28 Oct 2011

NK cells can fight against anthrax

One of the things that makes inhalational anthrax so worrisome for biodefense experts is how quickly a relatively small number of inhaled anthrax spores can turn into a lethal infection. By the time an anthrax victim realizes he or she has something worse than the flu and seeks treatment, it's often too late; even the most powerful antibiotics may be no help against the spreading bacteria and the potent toxins they generate.

28 Oct 2011

Lenvatinib may achieve partial response in thyroid, endometrial, and renal cancers

Phase 1 clinical studies of the experimental anticancer drug lenvatinib indicate that it may achieve at least a partial response in thyroid, endometrial, and renal cancers and melanoma.

28 Oct 2011

Special team care reduces cumulated stroke risk after transient ischaemic attacks

Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team. That is the key finding from a study published in the November issue of the European Journal of Neurology.

28 Oct 2011

Enoxaparin can reduce risk of VTE in plastic surgery patients

For plastic surgery patients at high risk, treatment with the anticoagulant (blood-thinning) drug enoxaparin can reduce the risk of serious blood clot-related complications called venous thromboembolism (VTE), reports a study in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

28 Oct 2011

Nipple sparing mastectomy safe and effective option for breast cancer treatment

A new study suggests some women needing a lumpectomy or mastectomy to treat their breast cancer have another potential option that is safe and effective, say researchers at Georgetown. They say the procedure known as a nipple sparing mastectomy is also a viable surgical option for women who choose to have their breasts removed because of their increased risk of developing the disease.

28 Oct 2011

Million Hearts' goal to prevent a million heart attacks and strokes in five years

In the time needed to read out loud the headline on this story, someone has died from a stroke. Every 6 seconds, someone in the world dies from stroke. The Centers for Disease Control and Prevention, in support of World Stroke Day, Oct. 29, 2011, asks Americans to take immediate action to reduce their risk for stroke.

28 Oct 2011

La Jolla Institute becomes 5th participant in novel stem cell research collaboration

The La Jolla Institute for Allergy & Immunology has become the fifth organization in the prestigious Sanford Consortium for Regenerative Medicine, joining colleagues from the Salk Institute for Biological Studies, The Scripps Research Institute, University of California, San Diego and the Sanford-Burnham Medical Research Institute in the first-of-its-kind multi-institutional stem cell research collaboration.

28 Oct 2011

Blood News and Research

Scientists describe how protein acts as courier in cell signaling pathways

Patients with ANCA-associated vasculitis harbor Flt1 protein that blocks blood vessel repair

Three economic indicators linked with high risk of stroke

Special hospital team reduces cumulated risk of stroke in TIA patients

Social stressors around the transition into adulthood sow seeds of disease in middle age

No significant evidence of breast cancer after nipple-sparing mastectomy

DiaGenic reports operating revenue of NOK 276 thousand for third quarter 2011

Novel technique saves Gulf War veteran's forearm

Swapping IV medications with oral equivalents may save millions

Novel stem cells method may eliminate need for antirejection drugs in transplants

Fasudil drug shows promise against cerebral cavernous malformation

Nestin-driven oncolytic viruses show effectiveness in glioblastoma models

Advanced papillary thyroid cancer patients with BRAFV600E gene mutation at higher risk

NK cells can fight against anthrax

Lenvatinib may achieve partial response in thyroid, endometrial, and renal cancers

Special team care reduces cumulated stroke risk after transient ischaemic attacks

Enoxaparin can reduce risk of VTE in plastic surgery patients

Nipple sparing mastectomy safe and effective option for breast cancer treatment

Million Hearts' goal to prevent a million heart attacks and strokes in five years

La Jolla Institute becomes 5th participant in novel stem cell research collaboration

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News